| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G9012 |
Other specified case management service not elsewhere classified |
57,304 |
50,181 |
$11.79M |
| H0033 |
Oral medication administration, direct observation |
56,903 |
33,966 |
$8.09M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
126,833 |
71,537 |
$7.69M |
| H0016 |
Alcohol and/or drug services; medical/somatic (medical intervention in ambulatory setting) |
28,193 |
22,548 |
$5.55M |
| H0047 |
Alcohol and/or other drug abuse services, not otherwise specified |
12,948 |
6,405 |
$2.19M |
| H0004 |
Behavioral health counseling and therapy, per 15 minutes |
50,611 |
39,464 |
$2.08M |
| H0014 |
Alcohol and/or drug services; ambulatory detoxification |
7,914 |
4,161 |
$1.53M |
| H2010 |
Comprehensive medication services, per 15 minutes |
5,760 |
2,566 |
$608K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
5,324 |
4,284 |
$272K |
| 80305 |
|
38,491 |
27,792 |
$197K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
18,005 |
9,338 |
$166K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
1,802 |
1,369 |
$111K |
| 90832 |
Psychotherapy, 30 minutes with patient |
4,678 |
2,783 |
$68K |
| H0049 |
Alcohol and/or drug screening |
2,714 |
1,883 |
$51K |
| H0005 |
Alcohol and/or drug services; group counseling by a clinician |
1,968 |
1,580 |
$48K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
553 |
431 |
$42K |
| G2087 |
Office-based treatment for opioid use disorder, including care coordination, individual therapy and group therapy and counseling; at least 60 minutes in a subsequent calendar month |
3,030 |
2,517 |
$20K |
| 90834 |
Psychotherapy, 45 minutes with patient |
665 |
432 |
$10K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
705 |
465 |
$6K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,487 |
622 |
$4K |
| 99215 |
Prolong outpt/office vis |
30 |
28 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
256 |
124 |
$386.70 |
| 90837 |
Psychotherapy, 53 minutes with patient |
19 |
13 |
$114.44 |